Subscribe: Newswise Feature Channel: Women's Health
http://www.newswise.com/legacy/feed/channels.php?channel=143
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
antonio breast  breast cancer  breast  cancer symposium  cancer  digital  patients  researchers  san antonio  treatment  women 
Rate this Feed
Rating: 3 starRating: 3 starRating: 3 starRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Newswise Feature Channel: Women's Health

Newswise Feature Channel: Women's Health



This feature channel includes news on topics related to women's health.



Copyright: Copyright 2017 Newswise
 



Many Women Report Not Feeling Completely Informed about Breast Cancer Treatment Options, but Web-Based Tool Could Help

Fri, 15 Dec 2017 11:00:00 EST

Results from two separate studies in the Journal of the American College of Surgeons showed a decision aid tool may help mitigate the sense of urgency patients feel about making treatment decisions.



A Gold-Standard Cancer Treatment Is in Decline, and Money May Be Why.

Fri, 15 Dec 2017 09:05:49 EST

(image) Researchers have determined that offering brachytherapy for cervical cancer ends up costing hospitals money. That can leave hospitals -- and their patients -- in the lurch.



Scientists Pinpoint Gene to Blame for Poorer Survival Rate in Early-Onset Breast Cancer Patients

Thu, 14 Dec 2017 19:00:00 EST

A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.



Womb Natural Killer Cell Discovery Could Lead to Screening for Miscarriage Risk

Thu, 14 Dec 2017 10:05:28 EST

(image) For the first time the functions of natural killer cells in the womb have been identified.



Sixth Annual Benefit Raises More Than $3.4 Million for the Dubin Breast Center

Wed, 13 Dec 2017 13:05:28 EST

(image) The Dubin Breast Center of The Tisch Cancer Institute at the Mount Sinai Health System held its sixth annual benefit on Monday, December 11, 2017, at the Ziegfeld Ballroom in Manhattan.



UCLA Study Finds Link Between Breast Cancer Treatments and Cellular Markers of Aging

Tue, 12 Dec 2017 15:00:01 EST

(image) A new study has found that women who had received chemotherapy and/or radiation to treat breast cancer were more likely to have high levels of DNA damage and reduced activity of an enzyme involved in chromosome healing, compared to women who underwent surgery alone. The results suggest that some breast cancer survivors may be more vulnerable to biological changes associated with accelerated aging because of their prior treatment.



Mayo Clinic Bioethicist Megan Allyse, ph.d., Discusses 4 Key Things to Know About the Possibilities, Pitfalls of Gene Editing

Tue, 12 Dec 2017 10:05:47 EST

Gene editing has captivated scientists and medical providers with tantalizing visions of wiping out debilitating inherited diseases.



Clinicians Who Ignore Nitric Oxide (NO) Function Put Their Patients at Risk

Tue, 12 Dec 2017 09:00:34 EST

Dr. Nathan Bryan, Baylor College of Medicine and one of the leading experts in nitric oxide biochemistry and physiology said today, "healthcare providers, especially those helping patients with cardiovascular issues and age-related disease, are not using perhaps the most important 'tool' in their 'toolbox,' restoring nitric oxide function. Bryan organized and chaired a full day workshop on the Clinical Applications of Nitric Oxide held during the 25th American Academy of Anti-Aging Medicine World Congress.



Bioethicists Call for Caution in Use of Rare Experimental Fetal Therapy

Mon, 11 Dec 2017 08:00:08 EST

(image) Citing uncertainties about the risks and benefits of an experimental therapy for fetuses whose kidneys do not develop, bioethicists at Johns Hopkins and a team of medical experts are calling for rigorous clinical trials in the use of a potential treatment, known as amnioinfusion.



Soy, Cruciferous Vegetables Associated with Fewer Common Side Effects of Breast Cancer Treatment

Mon, 11 Dec 2017 00:05:00 EST

(image) Consuming soy foods (such as soy milk, tofu and edamame) and cruciferous vegetables (such as cabbages, kale, collard greens, bok choy, Brussels sprouts, and broccoli) may be associated with a reduction in common side effects of breast cancer treatment in breast cancer survivors, say a team of scientists.



New Mediola and OlympiAD Trial Results Offer Another Boon for PARP Inhibitors in Treatment of Advanced BRCA-Related Breast Cancer

Fri, 08 Dec 2017 18:00:00 EST

Patients with certain advanced hereditary breast cancers may have new treatments options on the horizon, according to two studies presented this week at the annual San Antonio Breast Cancer Symposium. Susan Domchek, MD, executive director of the Basser Center for BRCA at Penn's Abramson Cancer Center, will present new results from the Mediola and OlympiAD trials showing continued success of treating BRCA-related metastatic breast cancer with the PARP inhibitor olaparib with limited side effects for patients.



For Women with Genetic Risk, Bi-Annual MRI Beats Mammograms

Fri, 08 Dec 2017 18:00:00 EST

Intensive surveillance including a dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) exam every six months was far more effective in detecting breast cancer in younger women with a high-risk genetic profile than an annual mammogram. DCE-MRI every six months performed well for early detection of invasive breast cancer in high-risk women.



PARP Inhibitor Improves Progression-Free Survival in Patients with Advanced Breast Cancers and BRCA Mutations

Fri, 08 Dec 2017 09:05:09 EST

(image) In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over available chemotherapies for patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes.



Including Diagnosis Related Costs, 3-D Mammography Costs Less than Digital Mammography

Fri, 08 Dec 2017 08:00:00 EST

Although digital breast tomosynthesis (DBT), or 3-D mammography, costs more than a digital mammography (DM) screening, it actually may help rein in cancer screening costs, according to preliminary findings (PD7-05) presented by researchers from the Perelman School of Medicine at the University of Pennsylvania during the 2017 San Antonio Breast Cancer Symposium.



La Mamografia Digital Con Realce Por Contraste Es Comparable a La Resonancia MagneTica De Las Mamas DespueS Del Tratamiento O De La Quimioterapia

Thu, 07 Dec 2017 11:05:57 EST

La mamografia digital con realce por contraste es comparable a la resonancia magnetica de las mamas para evaluar el cancer mamario residual despues de la terapia endocrina adyuvante o de la quimioterapia, segun los resultados de un estudio presentado por los investigadores de Mayo Clinic.



Biological Factors Don't Completely Explain Racial Disparities for 'Good Prognosis' Breast Cancer

Thu, 07 Dec 2017 09:05:33 EST

(image) The biological features of patients' tumors partially explained a racial disparity for women with hormone receptor-positive, HER2-negative breast cancer, but UNC Lineberger researchers led by Katherine Reeder-Hayes, MD, MBA, MSc, said it didn't explain it completely. The preliminary findings were reported at the 2017 San Antonio Breast Cancer Symposium.



Study Shows Acupuncture Decreased Joint Pain in Breast Cancer Patients Treated with Aromatase Inhibitors

Thu, 07 Dec 2017 08:55:00 EST

Acupuncture decreased joint symptoms in women with early-stage breast cancer treated with aromatase inhibitors, according to a randomized, multicenter clinical trial led by researchers at NewYork-Presbyterian and Columbia University Irving Medical Center. The findings were presented at the San Antonio Breast Cancer Symposium, held Dec. 5 - 9.



Ribociclib Extends Progression-Free Survival in Pre-Menopausal Patients with Metastatic Hormone Receptor-Positive Breast Cancer

Thu, 07 Dec 2017 08:05:42 EST

(image) The addition of ribociclib, an inhibitor of the cell cycle, to standard hormone therapy significantly improved progression-free survival (PFS) in pre-menopausal patients with advanced hormone receptor-positive (HR+) breast cancer, according to results of the MONALEESA-7 Phase III clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.



Contrast-Enhanced Digital Mammography Comparable to Breast MRI in Evaluating Residual Breast Cancer After Systemic Neoadjuvant Therapy

Wed, 06 Dec 2017 18:00:00 EST

Contrast-enhanced digital mammography is comparable to breast MRI in evaluating residual breast cancer after neoadjuvant endocrine therapy or chemotherapy, according to the results of a study presented by Mayo Clinic researchers today at the 2017 San Antonio Breast Cancer Symposium.



Active Females: How Much Dietary Protein is Needed for Post-Exercise Recovery?

Wed, 06 Dec 2017 14:05:06 EST

(image) Latest Research Highlights from ACSM